Renal Medullary Carcinoma (RMC)
1 clinical trials · Condition
◉ Watch Renal Medullary Carcinoma (RMC)
| Record | Firm | Date |
|---|---|---|
| Compassionate Use of Ubamatamab (NCT07502716) | Regeneron Pharmaceuticals |
Track Renal Medullary Carcinoma (RMC) automatically
Every clearance here is in the API, with alerts when new ones post.